Talal AH[au] - Search Results

Year	Number of Results
1994	2
1995	1
1997	2
1998	1
2000	1
2001	3
2002	1
2003	5
2004	5
2005	4
2006	3
2007	8
2008	8
2009	7
2010	5
2011	7
2012	6
2013	12
2014	8
2015	5
2016	5
2017	9
2018	4
2019	4
2020	6
2021	2
2022	4

1

Acute and chronic diarrhea.

Talal AH, Murray JA. Talal AH, et al. Postgrad Med. 1994 Sep;96(3):30-46. doi: 10.1080/00325481.1994.11945891. Postgrad Med. 1994. PMID: 29211559

2

Toward precision prescribing for methadone: Determinants of methadone deposition.

Talal AH, Ding Y, Venuto CS, Chakan LM, McLeod A, Dharia A, Morse GD, Brown LS, Markatou M, Kharasch ED. Talal AH, et al. PLoS One. 2020 Apr 17;15(4):e0231467. doi: 10.1371/journal.pone.0231467. eCollection 2020. PLoS One. 2020. PMID: 32302325 Free PMC article.

3

Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment.

Talal AH, Venuto CS, Younis I. Talal AH, et al. Clin Pharmacol Drug Dev. 2017 Mar;6(2):206-212. doi: 10.1002/cpdd.336. Clin Pharmacol Drug Dev. 2017. PMID: 28263464 Free PMC article. Review.

4

Hepatitis C virus infection in USA: an estimate of true prevalence.

Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Chak E, et al. Among authors: talal ah. Liver Int. 2011 Sep;31(8):1090-101. doi: 10.1111/j.1478-3231.2011.02494.x. Epub 2011 Mar 16. Liver Int. 2011. PMID: 21745274 Review.

5

Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?

Sehgal M, Khan ZK, Talal AH, Jain P. Sehgal M, et al. Among authors: talal ah. Virology (Auckl). 2013 Feb 11;4:1-25. doi: 10.4137/VRT.S11046. eCollection 2013. Virology (Auckl). 2013. PMID: 25512691 Free PMC article. Review.

6

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.

Afdhal NH, Zeuzem S, Schooley RT, Thomas DL, Ward JW, Litwin AH, Razavi H, Castera L, Poynard T, Muir A, Mehta SH, Dee L, Graham C, Church DR, Talal AH, Sulkowski MS, Jacobson IM; New Paradigm of HCV Therapy Meeting Participants. Afdhal NH, et al. Among authors: talal ah. J Viral Hepat. 2013 Nov;20(11):745-60. doi: 10.1111/jvh.12173. J Viral Hepat. 2013. PMID: 24168254 Free PMC article. Review.

7

Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care.

Zeremski M, Zibbell JE, Martinez AD, Kritz S, Smith BD, Talal AH. Zeremski M, et al. Among authors: talal ah. World J Gastroenterol. 2013 Nov 28;19(44):7846-51. doi: 10.3748/wjg.v19.i44.7846. World J Gastroenterol. 2013. PMID: 24307778 Free PMC article. Review.

8

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.

Dimova RB, Zeremski M, Jacobson IM, Hagan H, Des Jarlais DC, Talal AH. Dimova RB, et al. Among authors: talal ah. Clin Infect Dis. 2013 Mar;56(6):806-16. doi: 10.1093/cid/cis1007. Epub 2012 Dec 7. Clin Infect Dis. 2013. PMID: 23223596 Free PMC article. Review.

9

Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.

Cheruvu S, Marks K, Talal AH. Cheruvu S, et al. Among authors: talal ah. Clin Liver Dis. 2007 Nov;11(4):917-43, ix-x. doi: 10.1016/j.cld.2007.08.007. Clin Liver Dis. 2007. PMID: 17981235 Review.

10

A framework for patient-centered telemedicine: Application and lessons learned from vulnerable populations.

Talal AH, Sofikitou EM, Jaanimägi U, Zeremski M, Tobin JN, Markatou M. Talal AH, et al. J Biomed Inform. 2020 Dec;112:103622. doi: 10.1016/j.jbi.2020.103622. Epub 2020 Nov 10. J Biomed Inform. 2020. PMID: 33186707 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results